Increased phosphorylation of ERK1/2 is associated with worse chemotherapeutic outcome and a poor prognosis in advanced lung adenocarcinoma
Crossref DOI link: https://doi.org/10.1007/s00795-015-0130-3
Published Online: 2015-12-24
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tsujino, Ichiro
Nakanishi, Yoko
Hiranuma, Hisato
Shimizu, Tetsuo
Hirotani, Yukari
Ohni, Sumie
Ouchi, Yasushi
Takahashi, Noriaki
Nemoto, Norimichi
Hashimoto, Shu
Text and Data Mining valid from 2015-12-24